DHG Pharmaceutical JSC
DHG Pharmaceutical は、270 g 以上を生産するベトナム最大の国内上場医薬品メーカーです。
DHG Pharmaceutical はベトナム最大の国内上場医薬品メーカーで、抗生物質、ビタミン、OTC 鎮痛薬など 270 以上のジェネリック医薬品を製造しています。同社はWHO-GMP認証を取得しており、ベトナム全土の病院、薬局、医薬品卸売業者を通じて販売しています。日本の大正製薬がかなりの少数株を保有している。
- Type
- Manufacturer
- Location
- Can Tho, Vietnam
- Founded
- 1974
- Website
- dhgpharma.com.vn
- Categories
- 医療およびヘルスケア用品, サプリメントとウェルネス
- Markets
- ベトナム, カンボジア, ミャンマー (ビルマ), ラオス
Verified facts
- sanctions-clear (green), checked 2026-08-05 OpenSanctions
- debarment-clear (green), checked 2026-08-05 OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-05 Mail server of the company domain
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)